Journal of Endodontics
Volume 29, Issue 1 , Pages 51-54, January 2003

Antimicrobial Activity of Ca(OH)2 Dental Cements: An In Vitro Study

Drs. Morrier and Barsotti are associate professors, Service d’Odontologie Pédiatrique, Faculté d’Odontologie, Lyon, France. Mrs. Benay is an engineer, Dr. Barsotti is head, and Dr. Morrier is affiliated with Laboratoire d’Etude des Interfaces et des Biofilms en Odontologie, UFR d’Odontologie, Université Claude Bernard Lyon I. Dr. Hartmann is in private practice.

The effect of five commercial calcium hydroxide root canal medications (XR-SPAD, Calcicur, Hy-cal, Root-cal, Hypo-cal) and two calcium hydroxide mixtures (with water or glycerin) on the growth of (a) three anaerobic bacteria associated with endodontic infections; and (b) saliva bacterial strains was determined using the agar diffusion inhibitory test. Statistically significant zones of bacterial growth inhibition for all the bacteria tested were observed. Calcium hydroxide mixed with glycerin showed the largest zones of bacterial inhibition, whereas Root-cal was the least active. These results underline the necessity to evaluate the antibacterial potential of endodontic medications against the different bacterial strains commonly isolated from infected root canals.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 20.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The authors thank Laboratoire Interpromed (International Products, Paris, France), Laboratories Pierre Rolland (Mérignac, France), Laboratoire SPAD (Dijon, France), and Laboratoire VOCO (Cuxhaven, Germany) for supplying calcium hydroxide medications.This study was supported by a grant from the University Claude Bernard—Lyon I.

PII: S0099-2399(05)60796-0

doi:10.1097/00004770-200301000-00014

Journal of Endodontics
Volume 29, Issue 1 , Pages 51-54, January 2003